Arctic Vision has announced its acquisition of MDCO Technology's ophthalmic device business to create a comprehensive platform for drug-device innovation in the global ophthalmic market.

Target Company Overview

Arctic Vision (Cayman) Limited, based in Shanghai, is a leading global company in the ophthalmic sector. Recently, Arctic Vision announced its intention to acquire the ophthalmic device business of MDCO Technology, a prominent medical device firm headquartered in Hangzhou, China. This acquisition includes MDCO's innovative portfolio, which comprises premium intraocular lenses (IOL), implantable contact lenses (Phakic Lens), and various refractive device platforms.

This integration is set to enhance Arctic Vision's capabilities by merging advanced device engineering and intelligent manufacturing with their existing innovation initiatives, reinforcing their position within the global ophthalmic market.

Industry Overview in China

The ophthalmic medical device industry in China is growing rapidly, driven by increasing awareness of eye health and a higher incidence of vision-related problems. As the population ages, there is a rising demand for advanced opt